Clinical milestones for the prediction of severe anemia by chronic hepatitis C patients receiving telaprevir-based triple therapy.
J Hepatol
; 59(4): 667-74, 2013 Oct.
Article
em En
| MEDLINE
| ID: mdl-23707372
Palavras-chave
AUROC; Anemia; CI; HCV; HR; Hb; Hepatitis C virus; ITPA; Inosine triphosohatase; PegIFN; Pegylated interferon; RBV; RVR; Ribavirin; SNP; SVR; TVR; Telaprevir; area under the receiver operating characteristic curve; confidence interval; eGFR; estimated glomerular filtration rate; hazard ratio; hemoglobin; hepatitis C virus; inosine triphosphatase; pegylated interferon; rapid virological response; ribavirin; single nucleotide polymorphism; sustained virological response; telaprevir
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Antivirais
/
Oligopeptídeos
/
Hepatite C Crônica
/
Anemia
Tipo de estudo:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J Hepatol
Assunto da revista:
GASTROENTEROLOGIA
Ano de publicação:
2013
Tipo de documento:
Article
País de afiliação:
Japão